Outpatient chemotherapy for recurrent and/or advanced squamous cell carcinoma of the head and neck

International Journal of Clinical Oncology

Volumn 4, Issue 5, 1999, Pages 285-288

  Kohno, Naoyuki ^a   Kitahara, Satoshi ^a   Kawaida, Masahiro ^b   Ichikawa, Ginichiro ^c   Shirasaka, Tetsuhiko ^d  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 Fluorouracil; Chemotherapy; Cisplatin; Head and neck cancer; Outpatient setting

Indexed keywords

CISPLATIN; FLUOROURACIL; TEGAFUR; URACIL;

ADULT; AGED; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEAD CANCER; HUMAN; LEUKOPENIA; MALE; NECK CANCER; ORAL DRUG ADMINISTRATION; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; SQUAMOUS CELL CARCINOMA;

EID: 0032729947     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470050069     Document Type: Article

References (14)

1. Million RR (1985) Cancer of the head and neck. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, vol 1, 2nd edn. Lippincott, Philadelphia, pp 407-506
2. Rowland KM, Taylor SG, Spiers AS, et al. (1986) Cisplatin and 5-FU infusion chemotherapy in advanced recurrent cancer of the head and neck. Cancer Treat Rep 70:461-464
3. Ervin TJ, Weichselbaum R, Miller D, et al. (1981) Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep 65:787-791
4. Kohno N, Ichikawa G, Shirasaka T, et al. (1995) Salvage chemotherapy with PEM and Long-CF regimens in CDDP refractory advanced head and neck cancer. Jpn J Cancer Chemother 22:209-214
5. Jacobs C, Lyman G, Velez-Garcia E, et al. (1992) A phase II randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10:257-263
6. Forastiere AA, Metch B, Schuller DE, et al. (1992) Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck. J Clinc Oncol 10:1245-1251
7. Kohno N, Ohnuma T, Billar HF, Holland J (1988) Effects of cisplatin plus fluorouracil vs cisplatin plus cytarabine on head and neck squamous multicellular tumor spheroids. Arch Otolaryngol Head Neck Surg 114:157-161
8. Levin L, Hryniuk WM (1987) Dose intensity analysis of chemotherapy regimen in ovarian carcinoma. J Clin Oncol 5:756-767
9. Ota K, Taguchi T, Kimura K (1988) Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 22:333-338
10. Valverde JJ, Gonzalez JL, Dominguez S, et al. (1993) Neoadjuvant chemotherapy with cisplatin and 5 fluoro-uracil versus cisplatin and floraful-uracil in advanced head and neck cancer. Proc Am Assoc Clin Oncol 12:281
11. Fujii S, Kitano S, Ikenaka K, et al. (1980) Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil. Gann 71:100-106
12. Hanaue H, Kurosawa T, Kitano Y, et al. (1987) Anticancer drug distribution in lymph and blood during adjuvant chemotherapy after surgery for gastric carcinoma. Cancer (Phila) 59:1571-1576
13. Gamba A, Romano M, Grosso IM (1992) Psychosocial adjustment of patients surgically treated for head and neck cancer. Head Neck 14:218-233
14. Simon R, Wittes RE (1985) Methodologie guideline for reports of clinical trials. Cancer Treat Rep 69:1-3